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I.Introduction
Circulating proteins that specifically bind growth
hormone (GH) were originally reported in the rabbit (Ymer
and Herrington, 1985) and human (Baumann et al., 1986).
Recent efforts have led to the identification of GHBP in
domestic species including:sheep and horses (Davis et al.,
1992); pigs (Daughaday et al., 1987a; Mullins and Davis,
1992); and poultry (Vasilatos-Younken et al., 1991; Davis et
al., 1992; Anderson et al., 1992).
Sequencing of rabbit (Leung et al., 1987; Spencer et
al., 1988) mouse (Smith et al., 1989) and rat GHBP (Mathews
et al., 1989) have led to the observation that GHBP is
identical to the extracellular portion of the GHR.The
relationship between GHBP and GHR was further demonstrated
in studies that showed positive correlations between serum
GHBP and hepatic GHR activity (Hochberg et al., 1990, Bick
et al., 1990, Massa et al., 1990).In addition, GH
deficient humans (Laron-type dwarfism) have been reported to
have no detectable high affinity GHBP (Baumann et al.,
1987b; Daughaday and Trivedi, 1987).It has been suggested
that circulating GHBP is the product of the proteolytic
cleavage of the GHR (Baumann et al., 1986; Herrington et
al., 1986).Others have identified a unique mRNA encoding
GHBP in mice and rats (Smith et al., 1989; Baumbach et al.,
1989) .2
With the exception of a short hydrophobic tail, this unique
mRNA is identical to mRNA encoding the extracellular domain
of the GHR.It has been suggested that this unique GHBP
mRNA is an alternately spliced GHR transcript.Each
hypothesis would suggest that GHBP and GHR are under the
same transcriptional controls.It is, therefore, reasonable
to assume that serum GHBP levels may be an acceptable
indicator of GHR status in some animals.
Evidence for biologic roles for the GHBP has recently
been reported.The growth promoting properties of GH were
enhanced by recombinant GHBP in vivo (Clark et al., 1991;
Cook et al., 1991).The half-life of GH is extended by the
vascular confinement of the GH-GHBP complex (Baumann et al.,
1987a).In vitro GHBP has been shown to inhibit GH
dependent adipogenesis (Lim et al., 1990).Thus, the
presence of circulating GHBP appears to be relevant to
growth.
Avian GHBP has been identified and partially
characterized (Vasilatos-Younken et al., 1991; Anderson et
al., 1992; Davis et al., 1992).However, quantitative
evidence of how various factors affect avian GHBP has not
been reported.This study was undertaken to determine
whether differing physiological states which affect GH, GHR,
and or GHBP in mammals also affect serum GHBP activity in
the chicken.3
II.Literature Review
Molecular Aspects of Growth Hormone
Growth Hormone (GH) is a protein secreted from the
somatotroph cells in the anterior caudal lobe of the
anterior pituitary gland. It has long been recognized that
GH promotes growth in numerous tissues in mammalian species.
Growth hormone contains approximately 190 amino acids and is
a single-chain polypeptide with 2 intrachain disulfide bonds
(Niall et al., 1973).Growth hormone belongs to a family of
related proteins including prolactin (PRL, Niall et al.,
1973) and placental lactogen (PL), which is also known as
chorionic somatomamotropin (Niall et al., 1971 and 1973;
Catt et al., 1967).The GH, PRL, and PL genes all code for
roughly 200 amino acids and the structural organization of
their exons and introns are identical (Parks et al., 1989).
Sequence homology and other evolutionary aspects of this
family of proteins have been discussed by Wallis et al.
(1975) and Parks et. al. (1989).Some evidence suggests
that GH and PRL descended from a common ancestral gene and
that these genes have been modified to encode PL.
Amino acid sequences of GH have been determined for a
number of animals.These include the rat (Seeburb et al.,
1977), pig (Seeburg et al., 1983), sheep, horse (Wallis,4
1978), whale (Tsubokawa and Kawauchi, 1985), bullfrog (Pan
and Chang, 1988), rhesus monkey (Li et al., 1986) and human
(Li et al., 1969).Avian pituitary GH has been purified
from the chicken (Farmer et al., 1974; Harvey and Scanes,
1977a; Leung et al., 1984); duck; pigeon; turkey (Farmer et
al., 1974); and ostrich (Papkoff et al., 1982).Recombinant
chicken GH (cGH) has also been produced (Souza et al.,
1984).Pituitary-derived cGH preparations have been
sequenced (Lai et al., 1984; Leung et al., 1984) and the
amino acid composition has also been derived from the
nucleotide sequences of avian GH cDNA (Lamb et al., 1988 and
Chen, et al., 1988).Scanes et al.(1986) has compared the
sequences of rat, bovine, human, and chicken GH.Sequence
homology for chicken and rat GH (81%) and chicken and bovine
GH (77%) are considerably greater than chicken and human GH
(58%).
Growth hormone is heterogenic in mass and charge.
Human growth hormone, for example, exists in a 22 kDa form
and a 20 kDa form.This difference in mass has been shown
to be the result of differential mRNA splicing (DeNoto et
al., 1981 and Cooke et al., 1987).GH heterogeneity is also
influenced by multiple genes encoding GH variants, potential
sites for glycosylation and proteolytic cleavage events
co/postranslationaly, dimerization and a tendency to form
large aggregates, carrier/binding-protein interactions,5
fragment formation (by way of harsh extraction procedures),
N-acylation, deamidation and phosphorylation (Baumann,
1987) .
GH heterogeneity is common to many classes of
vertebrates, including mammals (Hart et al., 1984; Chawla et
al., 1983; Liberti et al., 1985), reptiles (Yasuda et al.,
1989), fish (Kawauchi et al., 1986) and chicken (Houston and
Goddard, 1988).Houston and Goddard (1988) described 10
different protein bands after isoelectrofocusing and
immunoblot analysis of pituitary derived chicken GH (cGH).
Isoelectric points ranged from 8.45 to 6.0, with 7.85 being
the predominant variant.SDS-PAGE and western blot analysis
of purified pituitary cGH and pituitary extracts showed four
immunoreactive band of 16, 22, 26 and 52 kDa (Aramburo et
al., 1990a).Further studies confirmed the existence of 4
GH variants in chicken serum identical to those found in the
pituitary gland (Montiel and Aramburo, 1992). Aramburo et
al.(1990a), also demonstrated that 2 of three 3 charge
variants, isolated by Non-denaturing-PAGE, possessed
different bioactivities.One form conveyed lipolytic
activity while the other conveyed an antilypolytic response.
Heterogeneity of cGH has been associated with differential
glycosylation (Berghman et al., 1987) and phosphorylation
(Aramburo et al., 1990b).6
The cGH most commonly occurs as a monomer of 22-23 kDa
with an isoelectric point of 7.5 (Farmer et al., 1974;
Harvey and Scanes., 1977; Burke and Papkoff, 1980). It has
been shown, through sequencing of its cDNA, that cGH
consists of a 191 amino acid protein in addition to a 25
amino acid segment which is not expressed in the mature,
circulating chicken GH (Lamb et al., 1988; Zhvirblis et al.,
1987) .
The Regulation of Growth Hormone Secretion
The release of GH is episodic in mammals, including
rats (Tannenbaum and Martin, 1976), cattle (Anfinson et al.,
1975), sheep (Davis et al., 1977), primates (Stewart et al.,
1981) and birds (Shaw et al., 1987; Vasilatos-Younken and
Leach, 1986; Buonomo, et al.,1984; Vasilatos-Younken and
Zarkower, 1987).The release of GH is under the control of
hypothalamic neuropeptides, of which two (thyrotropin
releasing hormone, TRH and growth hormone releasing factor,
GRF) are stimulatory and one (somatostatin or somatotropin
release inhibiting factor, SRIF) is inhibitory (Harvey et
al., 1978; Tannenbaum, 1991).The release of these
neuropeptides is under the control of neurotransmitters
within the CNS that innervate the hypothalamus and transfer
neural information to hormone-secreting hypothalamic neurons
(peptidergic neurons).Neurons containing the biogenic
amines, dopamine, norepinephrine and epinephrine, are, in7
turn, thought to be the primary regulators of hypothalamic
neuropeptide release (Terry et al., 1982; Eden et al.,
1981).Therefore, control of GH release is ultimately
dependant on CNS responses to external and internal stimuli.
Self-regulation of GRF and SRIF occurs via ultrashort loop
negative feedbacks at the hypothalamic level.
A number of other factors have also been shown to
influence GH secretion and have been reviewed by McCann
(1988) and Scanes (1986). Growth hormone regulates its own
release at the hypothalamic and pituitary level via short
loop feedbacks.Insulin-like growth factor-1 also exerts
negative feedback on the release of GH (McCann, 1988).
Serotonin, prostaglandin (El, E2 and F2a),high blood glucose
levels and androgens have been implicated in the inhibition
of GH release (Scanes, 1986).On the other hand, nutrient
deprivation, goitrogen administration, autoimmune
thyroiditis and iodothyronine-deficient dwarfism elevate
plasma GH concentrations (Scanes, 1986).Hypothalamic
defects can cause aberrant GH levels, as is the case in
hypopituitarism and acromegaly (McCann, 1988).
A general pattern of GH release has been recognized in
birds.Plasma concentrations of GH are high in the early,
post-hatch broiler chickens, where they peak (175 ng/mL
plasma) at about 2 wk of age.After this peak, GH levels
decline and remain relatively low (25 ng/mL plasma).This
pattern has been observed in chickens (Harvey et al, 1979;8
Vasilatos-Younken and Zarkower, 1987); turkeys (Harvey et
al., 1977; Proudman and Wentworth, 1980; Bacon et al.,
1989); doves (Scanes and Balthazart, 1981) and geese (Scanes
et al., 1979), although the age at which the GH peak was
observed varies between avian species and breeds.Evidence
also exists that GH secretion is sexually dimorphic in birds
(Harvey et al., 1979; Harvey et al., 1977b; Shaw et al.,
1987; Bacon et al., 1989).
The Action of Growth Hormone
GH has long been known to have an important role in the
regulation of somatic growth.It appears that GH has both
direct and indirect actions in the regulation of nutrient
utilization. The indirect action is mediated through
insulin-like growth factors (IGFs), also known as
somatomedins, which are produced in many tissues including
the intestine, heart, liver, kidney, lung, brain and
fibroblasts (reviewed by Luskey, 1988).
In vivo GH has been reported to promote growth in many
tissues including cartilage, adipose tissue, smooth and
skeletal muscle and lymphoid organs. (Isaksson, 1985).
Exogenous mammalian GH administration has been reported to
increase growth rate in many intact vertebrates including
mammals, reptiles, amphibians, and fish (Scanes et al.,
1986) .9
In contrast,administration of mammalian GH in normal,
intact birds has been ineffective in stimulating growth
(Scanes et al., 1984). However, mammalian GH did
stimulate growth in hypophysectomized chickens, while
control hypophysectomized birds showed a reduction in growth
rate (King and Scanes, 1985). Meyers and Peterson (1974)
reported that administration of a tryptic digest of bovine
GH (bGH) could stimulate growth in chickens.It has been
suggested that the tryptic digest of bGH was able to
stimulate growth because some especially antigenic bGH
component was removed by the digestive treatment (Vasilatos-
Younken and Scanes, 1991).In a study conducted by Scanes
et al.,(1975) bGH caused increased growth of the liver and
epiphyseal cartilage and increase spleen RNA content in
chickens.Also, ovine GH was able to stimulate plasma
levels of free fatty acids in pigeons (John, et al., 1973).
A recombinant bGH was able to stimulate a growth response in
the chicken after one wk of treatment (Buonomo and Baile,
1988).However, after a two wk treatment, the response was
lost and high antibody titres against the recombinant bGH
were detected.It has, therefore, been suggested that it is
the avian antigenic response that has been responsible for
lack of mammalian GH activity in birds.If that theory is
correct, only short term treatment and response studies10
using mammalian GH would give a response to any foreign GH,
as is the case with the mammalian GH studies mentioned above
(Vasilatos-Younken and Scanes, 1991).
Surprisingly, administration of pituitary-purifiedor
recombinant cGH has not been shown to substantially or
consistently enhance growth in early posthatch birds when
administered byinjections or continuous infusion
(Vasilatos-Younken and Scanes, 1991).Treatment regimes
(pulsatile versus continuous cGH administration) andage of
birds, late posthatch versus early posthatch, have been
reported to play an important role indetermining the
metabolic response to GH administration (Vasilatos-Younken
and Scanes, 1991).In their review, Vasilatos-Younken and
Scanes (1991) suggest that pulsatile administration of cGH
in late posthatch chickens improved growth rate and feed
efficiency and reduced lipogenesis.Continuous
administration of cGH, on the other hand, actually reduced
growth rate and feed efficiency and had no effect on
lipogenesis.
Molecular Aspects of the Growth Hormone Receptor
The GH receptor (GHR) is a membrane-bound protein
molecule that, upon binding GH, leads to a variety of
biological responses.The mechanism of the signal
transduction is not well understood.11
The evidence for and the identification of second messengers
for GHR is conflicting.Some observations have suggested
that GHRs are associated with guanylate cyclase activity,
tyrosine kinase activity, protein kinase C and the
production of diacylglycerol and inositol triphosphate
(Kelly et al., 1991).Crystals of the human GH-GHR complex
have revealed that GH binds to the extracellular portion of
the GHR in a stoichiometry of one GH molecule to two
molecules of GHR (Cunningham et al., 1991; de Vos, et al.,
1992).This dimerization process occurs sequentially and is
thought to be relevant to the signal transduction mechanism.
Complementary DNA sequences of the GHR from rabbit
(Leung et al., 1987), sheep (Adams et al., 1990), mouse
(Smith et al., 1989), rat (Baumbach et al., 1989; Mathews et
al., 1989), human (Leung et al., 1987), and cow (Hauser et
al, 1990) encode a protein with a calculated molecular
weight (MW) of approximately 70 kD.However, analysis of
mammalian GHRs identified by western blots and SDS-PAGE
indicate the existence of MW variants ranging from 130 kD to
50 kD (Hocquette et al., 1990; Leung et al., 1987; Spencer
et al., 1988 and Yamada and Donner, 1984).According to
Hocquette et al.(1990) and Yamada and Donner (1984)
discrepancy in apparent MW of GHR is associated with
glycosylation and the binding of ubiquitin and limited
proteolysis.The MW heterogeneity of the GHR has also been12
associated with multiple subtypes of the GHR (Barnard et
al., 1985) and possible associations with other membrane-
bound proteins (Taga et al., 1989). The GHR contains an
extracellular domain of 242 amino acids, a single
transmembrane-spanning domain of 24 amino acids, and a
cytoplasmic domain of 350 amino acids.
The chicken GHR (cGHR) has also been cloned, but it
shares only a 58% overall homology with reported sequences
of mammalian GHR (Burnside et al., 1991).Chicken GHR cDNA
encoded for a mature peptide of 592 amino acids with a
predicted MW close to that reported for mammalian GHR.
Burnside et al.(1991) found that cGHR was expressed in many
tissue types, including liver; skin; heart; lung; bursa;
kidney; muscle; cerebellum; cerebrum; testes; and adrenals.
The Regulation of Growth Hormone Receptors
The biological response to a given amount of GH is
dependant on the number of membrane bound GHR (Landron et
al., 1989; and Straus and Takemoto, 1990). Thus, receptor
turnover may play an important role in the regulation of the
tissue responsiveness to GH.The half-life of membrane
bound GHR is about 30 min (Gorin et al., 1984).A higher
proportion of GHR are localized within the endosomal
compartment of hepatic cells than are associated13
with hepatic plasma membrane (Picard and Postel-Vinay, 1984
and Hocquette et al., 1989), suggesting that GHR are
internalized.More direct evidence of receptor
internalization has been reported as well (Roupas and
Herrington, 1988).Treatment of adipocytes with
cycloheximide or puromycin (inhibitors of protein synthesis)
decreasedGH binding activitywith increasing exposure to
either inhibitor (Gorin and Goodman, 1985), suggesting that
GHR are not recycled as is typically observed in receptor-
mediated endocytosis (Brown et al., 1983).Therefore,
mechanisms involved in the de novo protein synthesis of GHR
may play an important role in GHR capacity and the type of
response GH target cells produce.
Many factors have been implicated in the regulation of
GHR. Nutritional status is important to membrane-bound GHR
capacity.Several days of fasting in rats resulted in over
a 50% decrease in the number of hepatic GHR and refeeding
restored GHR numbers (Postel-Vinay et al., 1982; Baxter et
al., 1981).Addition of glucose prevented a decrease in GH
binding activity observed in glucose-poor media cultures of
rat hepatocytes (Niimi et al., 1991).Levels of circulating
GH are also implicated in the regulation of its own
receptor.Adipose cells from hypopsectomized rats had low
GH binding activity that was increased 2-fold by treatment
with bovine GH (Grichting and Goodman, 1986).14
In vivo studies have complicated the picture of GHR
regulation by GH.Apparently, the pattern of exogenous GH
administration is an important factor in the determining GH-
related responses in the turkey (Vasilatos-Younken et al,
1988; Cravener et al., 1990). Thus, continuous and pulsatile
administration of GH in birds produce different responses
that may relate directly or indirectly to the regulation of
GHR.Administration of GH caused an induction in hepatic
GHR in pigs (Ambler et al., 1990) and rats (Baxter and
Zaltsman, 1984). Other factors that have been reported to
affect GHR response include estrogen; insulin; sex; age;
pregnancy; and dwarfism (see Kelly et al., 1991 for review).
Few studies have examined the regulation of the avian
GHR.The ontogeny of hepatic GHR activity in chickens has
been examined by Vanderpooten et al.(1991).Relatively
high hepatic GHR activity was found in chicken embryos and
adult chickens (2 yr old).A dramatic decrease in GHR
activity was observed at hatch and relatively low GHR
activity was maintained through 8 wk of age.Post-hatch
ontogeny of hepatic GHR activity in turkeys remained
relatively low from 2 wk of age to 15 wk of age, while older
turkeys (24 wk of age) showed much higher GHR activity
(Vasilatos-Younken et al., 1990).A recent study found that
chicken hepatic GHR mRNA transcription was developmentally
regulated in such a way that low levels were transcribed in15
young birds, while transcription increased significantly in
birds which were 6 to 8 wk of age (Oldham et al., 1992).
The effect of sex and endogenous plasma GH on turkey
GHR activity was examined by Vasilatos-Younken et al.(1990)
as well.Sexual dimorphism was significant only in adult
turkeys, where females exhibited more GHR binding activity
that males.Correlations between plasma GH and GHR binding
activity were significant only in adult turkeys (r=-.55).
Leung et al.(1986) gave daily injections of GH to chickens
and observed down-regulation of GHR binding activity as
well.Correlations between low GHR binding activity and
dwarfism (Vanderpooten et al., 1991) have been observed.In
addition, a restriction fragment length polymorphismwas
found in sex-linked dwarf chicken GHR DNA (Burnside et al.,
1991), and it was reasoned that this deletion was
responsible for biologically defective GHR.
The Identification and Characterization of Circulating
Growth Hormone Binding Proteins
Observations of a GH plasma binding protein was
considered as early as the 1960's (Hadden and Prout, 1964;
Collipp et al., 1964).These reports were dismissed as
artifacts of protein purification/iodination procedures and
went against current dogma of the status of circulating
peptide hormones.It was not until the 1980's that a16
definitive GHBP was reported in the rabbit (Ymer and
Herrington, 1985) and human by two independent researchers
(Baumann, et al., 1986; Herrington et al., 1986).
Researchers have since discovered GHBP in mice (Sadeghi et
al., 1990; Cramer et al., 1992); poultry (Vasilatos-Younken
et al., 1991; Davis et al., 1992); pigs (Daughaday et al.,
1987b; Mullins and Davis, 1992; Ambler et al., 1992); rats
(Bick et al., 1990; Massa et al., 1990; Amit et al., 1990;
Tiong and Herrington, 1991a); cattle; sheep and horses
(Davis et al., 1992); and dogs (Daughaday et al., 1987a).
Baumann and Shaw (1990) observed two circulating human
forms of GHBP, one of low affinity (Ka,105 M-1), with a MW
of 100 kD, a maximum binding capacity (Bmax) of 15 mg hGH/L
plasma and an isoelectric point (pI) of 7 when complexed to
hGH.The other higher affinity(Ka=3 X 108 M-1) GHBP had a
MW of 60 kD, a Bmax of 20 Ag hGH/L plasma and a pI of 5 when
complexed to hGH.The lower Ka GHBP was shown to carry
about 10-15% of the bound circulating GH (4-7% of total
circulating GH).Rat GHBP also has twovariants, one at
200 kD GHBP and another at 90 kD GHBP (Massa et al., 1990).
Although these two rat GHBP were not characterized
individually,the collective Ka(2 x 108 M-1) was not
sexually dimorphic, but the Bmaxwas higher in females (6.4
x 10-8 mol bGH/L) than in males (1.6 x10-8 mol bGH/L).17
Rabbit GHBP has been characterized both in recombinant form
(Leung et al., 1987) and as a serum purified product
(Spencer et al., 1988).Both research groups observed a 51
kD rabbit GHBP with an affinity of 6 x 109 14-1 for hGH.
Davis et al.,(1992) has characterized serum GHBP purified
from the pigs and sheep.Porcine GHBP MW was approximated
at 50-60 kD with an affinity of 1.55 x 109 L/mol and Bmax of
1.7 x 10
-10mol/mg GHBP for hGH.Sheep GHBP had an affinity
of 2.3 x 108 L/mol and a Bmax of 6.0 x 10-10 mol/mg GHBP for
hGH.Competitive binding experiments have revealed that
GHBP specifically binds GH except in one case where ovine PL
competed with porcine GH binding to porcine GHBP (Davis et
al., 1992).In almost all cases, GH binding to GHBP is
reversible as well as temperature and time dependant.
Identification of avian GHBP was first reported by
Vasilatos-Younken et al.(1991) and Davis et al.(1992).
Vasilatos-Younken's group determined that at least two cGHBP
of approximately 70 kD and 30 kD exist in chickens and
turkeys through SDS-PAGE, western blotting and
autoradiographic techniques using serum and plasma.Only
the larger MW cGHBP was shown to be glycosylated (cGHBP of
62 kD after enzymatic hydrolysis).Davis' group have
characterized partially purified serum binding proteins from
7 wk old broilers.The affinity was 1.55 x 109L serum/mol18
hGH and 2.07 x 107 L serum/mol cGH and theBmaxwas 1.7 x 10-
w mol cGHBP/mg hGH and 1.5 x 10-10 mol cGHBP/mg protein,
respectively.
The Amino Acid Sequence of Growth Hormone Binding Protein
The amino acid sequence of rabbit GHBP purified from
serum is identical to the extracellular portion (N-terminal)
of the rabbit GHR derived from a cDNA clone (Leung et al.,
1987) and purified from hepatic membranes (Spencer et al.,
1988).The mouse GHBP (Smith et al., 1989) and rat GHBP
(Baumbach et al., 1989; Mathews et al., 1989) have been
cloned and the amino acid sequences derived were equivalent
to the extracellular portion of the GHR with the exception
of a hydrophilic tail (17 amino acids in the rat and 8 amino
acids in the mouse) apparently in place of the hydrophobic
transmembrane domain of the GHR.
Although work is in progress, the chicken GHBP has not
been sequenced.A suspect chicken GHBP cDNA has been cloned
and expressed in COS-7 cells, but no definitive evidence has
yet been produce to confirm it as a cGHBP (Dr. L. A.
Cogburn, personal communications).19
The Origin of Growth Hormone Binding Protein
The origin of GHBP has been controversial.Through
sequence analysis of purified GHBP and comparisons to the
GHR, a relationship of the GHBP to the hydrophilic
extracellular domain of the GHR has been recognized.It has
been suggested that GHBP is a product of the proteolytic
cleavage and extracellular release of the growth hormone
receptor (Baumann et al., 1986; Herrington et al., 1986).
Many studies have shown positive correlations between levels
of GHBP and thenumber of GHR. Trivedi and Daughaday
(1988) have induced human IM-9 cells to shed GHBP from their
GHRs in vitro.Thus, it is speculated that GHR and GHBP are
similarly regulated.
In mice and rats a unique mRNA has been shown to encode
a GHBP (Smith et al., 1989; Baumbach et al., 1989).
Sadeghi et al.(1990) has reported that the rat mRNA that
encodes GHBP (1.2 kb) contains an alternately spliced exon
that codes for the short, hydrophobic, C-terminal tail that
takes the place of the transmembrane and intracellular
domain of the GHR.Tiong and Herrington (1991b) have also
identified a 2.6 kb GHBP mRNA in the rat that is expressed
only in hepatic tissue.The 2.6 kb tissue specific mRNA
differs from the 1.2 kb mRNA primarily with respect to the
length of the 3' untranslated portion of the mRNA.The
untranslated 2.6 kb mRNA may help researchers identifya20
second GHR-related gene, although the 2.6 kb mRNA could
certainly be the result of alternate splicing of the GHR.
The Biologic Role of Circulating Growth Hormone Binding
Protein
The role of GHBP is unknown, but evidence exists that
suggests some possible functions.The GHBP/GHR is expressed
in most tissues (Mathews et al., 1989).The localization of
GHBP to specific tissues/subcellular components has led to
many hypotheses.The rat GHBP gene was transcribed in all
tissues in which GHR mRNA was detected (liver, spleen,
heart, muscle, tongue, skin, kidney, adrenal and intestine),
although the major source of GHBP was hepatic tissue
(Carlsson et al., 1990).Thus, it was proposed that GHBP
may represent an additional control mechanism involved in
the balance between GH and GHR at a cellularly localized
level. Rat GHBP was found distributed throughout the male
and female reproductive system and it was suggested that
GHBP may exert a direct effect on reproductive function
(Lobie et al., 1990).A nuclear GHBP has been reported in
rabbit hepatic tissue (Lobie et al., 1991).Therefore,
Lobie et al.(1991) proposed that GHBP may be involved in GH
action at the nuclear level.Frick and Goodman (1992)
observed that GHBP was associated with particulate fractions
of rat adipocytes.This observation was unusual because of
the hydrophilic properties of GHBP. It was, therefore,21
suggested that GHBP may be associated with a membrane bound
protein involved in signal generation or transduction.
The growth promoting effects of recombinant human GH
(body weight gain, bone growth, liver weight gain and serum
IGF-1 stimulation) were enhanced by recombinant human GHBP
in a dose dependant manner in hypophysectomized rats (Clark
et al., 1991).Cook et al.(1991) got similar results using
dwarf rats as a model, but it was noted that although IGF-1
levels were increased, the levels of circulating IFG binding
proteins were not induced by the addition of recombinant
human GHBP.Consequently, it was proposed that the enhanced
growth response to GH induced by GHBP may be related to the
ability of the GHBP to alter the ratio between IGF-1 and its
binding protein (see De Mellow and Baxter, 1988 for a
discussion of IGF binding proteins).
Baumann et al.(1987a) used a partially purified human
GHBP preparation and 125I-hGH to test the metabolic clearance
rate, distribution volumes and degradation of hGH as
affected by GHBP in mice.It was concluded that GHBP was
associated with the confinement of hGH to the vascular
compartment.It was reasoned that, due to its large
molecular size, complexed hGH was prevented from being
filtered and excreted by the kidney and, therefore, was
protected from degradation, thus extending its half-life.
However, this proposed role of GHBP has been discounted by
some reports (Holl et al., 1991 and Paul et al., 1991).22
The GH-dependent stimulation of adipogenesis was
inhibited by serum purified human GHBP in vitro (Lim et al.,
1990).Lim and coworkers also found that human GHBP was
able to block 125I-hGH binding to IM-9 lymphocytes in a dose-
dependant manner.Thus, it was speculated that GHBP may
dampen the biological effect of pulsatile GH by reducing
free GH during secretory pulses, with the effect of
flattening the biologically active GH secretory profile.
The Ontogeny of Growth Hormone Binding Protein
The ontogeny of GHBP may play an important role in
developmental regulation of the response to GH and may be an
indicator of the ontogeny of the GHR as well.Human
circulating GHBP activity is low at early ages and increase
in a linear fashion (r=0.55, n=96) from a half yr old infant
to 40 yr of age (Tar et al., 1990).Human serum from
premature infants and adults over 60 yr of age had
relatively low GHBP activity compared to full term infants
and adults between the ages of 20-46 yr of age, respectively
(Daughaday et al., 1987b).
In the rat, serum GHBP activity increases steadily from
1 to 12 wk of age with a 5-10 fold increase in measured GHBP
activity (Mulumba et al., 1991).An ontological study in
rat from 19 d of gestation to 110 d of age revealed mRNA23
expression of GHBP and serum GHBP activity increased
steadily up to 40 d of age where adult plateau levels were
reached (Tiong and Herrington, 1992).Interestingly,
Tiong's group observed that, although reasonable
correlations existed between GHBP patterns and GHR mRNA
expression, a strong correlation existed between GHBP and
IGF-1 mRNA expression.However, Tiong and Herrington
(1991b) observed no change in the abundance of 2.6 GHBP mRNA
in from fetal age to 80 d old, but the 1.2 kb GHBP mRNA
increased with age during this same developmental period.
The ontogeny of GHBP in chickens has recently come
under scrutiny.Only qualitative information (via SD-PAGE
and western blotting of plasma proteins and visualization
using autoradiographic techniques with 125I-rcGH) exists for
determining the presence of cGHBP (Anderson et al., 1992).
Embryonic appearance of the 70 kD and 30 kD cGHBP (see
Vasilatos-Younken et al., 1991) did not occur until d 12 and
d 20 of incubation, respectively.Each cGHBPincreased
progressively from the age at which it was first observed to
1 d post-hatch.Although prominent at hatching, the 70 kD
cGHBP was greatly diminished and the 30 kD cGHBP was not
evident at 1 and 2 wk post-hatch, but both reappeared at 4
wk post-hatch and remained prominent at 6, 8, 12, and 18 wk
post-hatch.Interestingly, circulating GH followed an
inverse pattern to the observed patter of cGHBP expression.24
Growth Hormone Binding Protein and Sex
In the human, no sex differences have been observed
from infants to adults when using gel chromatography to
measure serum GHBP (Tar et al., 1990 and Snow et al., 1990).
However, techniques employing immunoprecipitation of GHBP
and 125I-hGH binding to GHBP were used together with
corrections made for endogenous hGH measured by
radioimmunoassay to give a more reliable estimate of human
GHBP capacity.Using this methodology, Barnard et al.
(1989) observed a sex related difference in GHBP capacity in
adult humans (female= 804 pmol/L; males= 505 pmol/L;
P<0.02).Rats have been reported to have sex related
differences in serum GHBP activity, but these difference
were not significant from 1 to 3 wk of age (Mulumba et al.,
1991).Female rats had significantly higher serum GHBP
activity at 6 (P<0.01) and 12 (P<.005) wk of age.Serum
from adult rats also showed significant sexually dimorphic
serum GHBP activity (Massa et al., 1990 and Amit et al.,
1990).However no sex differences were observed in the
abundance of the tissue specific 2.6 kb GHBP mRNA in rats
(Tiong and Herrington, 1991b).No sex effect on GHBP has
been reported for any avian species.25
Growth Hormone Binding Protein and Nutritional Status
Few studies have reported the effects of nutritional
status on circulating growth hormone binding protein.Rats
fasted for 3 d had significantly lower serum GHBP (P<0.001)
and upon refeeding serum GHBP activity returned to control
levels (Mulumba et al., 1991).The high affinity human GHBP
which is elevated in adipose children (Silbergeld et al.,
1989) was decreased after a 6 wk weight reduction program
(mean weight lost= 7.7 kg) and weight loss correlated with
high affinity GHBP reduction (r= 0.37, P<0.05; Holl et al.,
1992).However, the low affinity human GHBP increased
significantly (P<0.005) after the weight reduction program.
No cGHBP studies related to nutritional status have been
reported.
Growth Hormone Binding Protein and Stature
Perhaps the best example of the relationship between
the GHBP and the GHR can be observed as the result of a
growth hormone deficiency or biologically inactive GHR.The
short stature that is the phenotypic expression of Laron-
type dwarfism (LTD) is also characterized by low levels of
IGF and normal to high levels of GH (Laron et al., 1966).
There is evidence of a defective GHR in LTD patients (Eshet
et al., 1984). The high affinity serum GHBP in humans is
absent in some LTD patients (Baumann et al., 1987b;
Daughaday and Trivedi, 1987).26
The LTD phenotype has also been associated with variable
levels of high affinity serum GHBP (Rosenbloom et al.,
1990).However, the LTD phenotype is heterogenous and the
GHR gene shows variations (deletions, point mutations, or no
demonstrable abnormality) in the gene encoding the
extracellular domain of the GHR (Amselem et al., 1989 and
Godowski et al., 1989).Thus the variation in high affinity
serum GHBP in LTD patients is not unexpected.
An isolated population of receptor deficient patients
in Ecuador (Fielder et al., 1992) and African pygmies
(Baumann et al., 1989) had very low level of GHBP and IGF.
The Mountain Ok people of Papua New Guinea have
characteristic short statue with normal levels of IGF-I and
GH, yet the level of serum GHBP is half that of control sera
(Baumann et al., 1991).No data on GHBP in dwarf chickens
has been reported.
Growth Hormone Binding Protein and Pregnancy
Pregnancy in the rat caused a significant (P<0.02)
increase in the serum GHBP binding capacity in comparison to
rats in estrus, but no significant difference was observed
in GHBP activity (Amit et al., 1990).Tiong and Herrington
(1991a and 1991b) observed a pregnancy related increase in
the abundance of rat 1.2 kb GHR mRNA but no change was seen
in the 1.2 kb GHR mRNA.However, it was also observed that27
serum GHBP activity was significantly higher in pregnant
rats (female vs pregnant, P=0.005; Tiong and Herrington
1991a) .
The mouse serum GHBP measured by a radioimmunoassay was
found to steadily increase from 5 to 15 d of gestation and
was 32-fold higher than non-pregnant mice at 17 d of
gestation (Cramer et al., 1992).Sanchez-Jimenez et al.
(1990) reported that pregnant mice has significantly more
serum GHBP activity than virgin mice and hypophysectomized
pregnant mice experienced a reduced level of serum GHBP
activity that was not significantly different fromnon-
pregnant mice.
Growth Hormone Binding Protein and Hormones
In rats serum GHBP fluctuated, with a 60 min lag, with
naturally occurring GH pulses over a 4 h period (Bick et
al., 1990).Continuous delivery of hGH to hypophysectomized
rats caused a dose dependant increase in serum GHBP (Bick et
al., 1990).In another paper Bick et al.(1991) observed
that continuous delivery of human GH precipitated increased
serum GHBP in the rat to a greater degree than pulsatile
administration.
Daily administration of a recombinant porcine GHover a
12 d period caused elevated pig serum GHBP (P=0.03) levels
(Ambler et al., 1992).In another lab,long term treatment
(7 wk) with daily injections of recombinant porcine growth28
hormoneincreased serum GHBP levels (p<0.05), however
periodic treatment of recombinant porcine GH (daily, every
second d or every fourth d for two wk) did not cause a
significant difference in serum GHBP levels (Mullins and
Davis, 1992).Paradoxically, it appears that plasma cGHBP
levels have an inverse relationship to GH levels throughout
embryonic and post-hatch stages (Anderson et al., 1992).29
III.Factors Affecting Circulating Growth Hormone
Binding Protein in Chickensl
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Abstract
Growth hormone binding protein (GHBP) may be an
important factor in the regulation of growth as well as an
indirect, less invasive way of predicting the status of
growth hormone receptors.Several factors have been
reported to influence GH, GHR, and or GHBP.Therefore,
these studies were conducted to test how the factors of age,
sex, nutritional status and cortisone acetate,(CA) affected
serum levels of chicken GHBP.Serum GHBP activity was
highest (mean %SB= 14.6 ± 1.2) at hatch and decreased
linearly (r= -.9516) to 4 wk of age (mean %SB= 4.1 ± 0.6).
Sex had no significant affect on serum GHBP activity from
hatch to 4 wk of age.
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Short term nutrient deprivation (24 h fast) of 4 wk old
birds had no significant affect on serum GHBP activity, nor
did refeeding.Feeding birds nutrient poor diets (low
energy; low protein; or low energy and low protein )did not
significantly affect serum GHBP activity when compared to
birds fed a commercial broiler diet (23-21% crude protein
and 3151-3111 Kcal/Kg ME).Pulsatile delivery of cortisone
acetate (1,5 and 10 mg/d) had no affect on serum GHBP
activity at any dose.These results suggest that serum GHBP
activity in the chicken is not affected by many factors
which do influence GHBP in mammalian species.The lack of
response to the treatments used may be a factor related to
the age (hatch to 7 wk) of the birds used in these studies.
Key Word: Chicken, Growth Hormone Binding Protein, Growth.31
Introduction
Circulating proteins that specifically bind growth
hormone (GH) were originally identified in the rabbit (Ymer
and Herrington, 1985) and human (Baumann et al., 1986).
Recent efforts have led to the identification of GHBP in
domestic species (Davis et al., 1992; Daughaday et al.,
1987; Mullins and Davis, 1992).The following evidence
suggest the importance of growth hormone binding protein
(GHBP) as a potential non-invasive indicator of growth
hormone receptors (GHR) status .
Sequencing of rabbit (Leung et al., 1987; Spencer et
al., 1988) mouse (Smith et al., 1989) and rat GHBP (Mathews
et al., 1989) led to the observation that GHBP was identical
to the extracellular portion of the GHR.The relationship
between GHBP and GHR was further demonstrated in studies
that showed positive correlations between serum GHBP and
hepatic GHR activity (Hochberg et al., 1990; Bick et al.,
1990; Massa et al., 1990).In addition, GH deficient humans
(Laron-type dwarfism) have been reported with no detectable
high affinity GHBP (Baumann et al., 1987; Daughaday and
Trivedi, 1987).It has been suggested that circulating GHBP
is the product of the proteolytic cleavage of the GHR
(Baumann et al., 1986; Herrington et al., 1986; Leung et
al., 1987). However, unique GHBP mRNA in mice and rats are
similar to mRNA encoding the extracellular domain of the GHR
(Smith et al., 1989; Baumbach et al., 1989).32
It has been suggested that this unique GHBP mRNA is an
alternately spliced GHR transcript.Thus, each hypothesis
suggests that GHBP and GHR are, at least, under the same
transcriptional controls.It is, therefore, reasonable to
assume that serum GHBP levels may be an acceptable indicator
of GHR status in some animals.
The ontogeny of avian growth hormone receptors depict a
developmental regulation that confers relatively high levels
of GHR activity during embryonic stages and at the
initiation of sexual maturity through adulthood, while young
birds experience relatively low GHR activity (Vasilatos-
Younken et al., 1990.; Vandepooten et al, 1991).
Circulating GH profiles appear to have an inverse
relationship to the developmental pattern seen for GHR
(Vasilatos-Younken et al., 1990; Vasilatos-Younken and
Zarkower, 1987; Proudman and Wentworth, 1980), while
reported hepatic GHR activity (Vanderpooten et al., 1991)
appears to correlated positively with cGHBP (Anderson et
al., 1992).Avian GHBP has been identified and partially
characterized (Vasilatios-Younken et al., 1991; Davis et
al., 1992).
The objective of this study was to measure relative
circulating GHBP activity in chickens of various physiologic
states.33
Materials and Methods
Commercial broiler chickens (Keith Smith Farm, Hot
Springs, AK) were feather-sexed at hatch.Birds were fed
a starter ration (23% crude protein, CP and 3151 Kcal/Kg
metabolizable energy, ME; Table 1) from hatch to 4 wk of age
at which time a finisher ration (21% CP and 3111 Kcal/Kg ME;
Table 1) was fed through the remainder of each study unless
otherwise specified.In each study, birds were maintained
in a 24 h light photoperiod and given feed and water ad
libitum, unless otherwise specified.
Birds were weighed and wing banded prior to each blood
collection.Blood was collected by severing the cutaneous
ulnar vein in birds younger than 3 wk of age. In older
birds blood was collected from the cutaneous ulnar with 4 mL
vacutainertubes.Blood was drawn from each bird one time
only.Blood samples were allowed to clot for 2 h at room
temperature.Clots were separated from serum by
centrifugation at 2000 x g at 4° C for 10 min.All serum
was stored in microfuge tubes between 9 to 12 mo at -20° C
until assayed.
Experiment 1.Male and female birds were housed in separate
pens, 76 of each sex per pen.Blood samples were collected
from 15 birds of each sex at hatch, 1,2,3, and 4 wk of
age.34
Experiment 2.Male birds were randomly assigned to control
(n=60) or treatment (n=60) groups.When chickens reached 4
wk of age feed was removed from the treatment group for 24
h.After the fast, birds were fed ad libitum.Blood
samples were drawn 24 h after fasting and 12, 24 and 48 h
after refeeding.
Experiment 3.Male birds were divided into a control and
three treatment groups.Each group contained 65 birds.
When the chickens reached 13 d of age, the starter ration
was removed from each treatment group and replaced with one
of the following:a low protein ration (12% CP and 3154
Kcal/Kg ME; Table 2), low energy ration (21% CP and 2664
Kcal/Kg ME; Table 2), or a low protein-low energy ration
(12% CP and 2582 Kcal/Kg ME; Table 2).Blood collection
began at 14 d of age and was performed once each wk through
7 wk of age.
Experiment 4.A total of 190 male birds were randomly
assigned to a control and three treatment groups.All birds
received daily injections in the breast muscle beginning at
5 wk of age and continuing for a wk.Treatment birds were
injected once a d with a 1,5 or 10 mg suspension of
cortisone acetate (CA; Sigma Chemical Co., St. Louis, MO,
U.S.A.) in 0.5 mL of corn oil. Control birds were injected
with 0.5 mL of corn oil alone.35
Blood was collected 24 h,8 d and 2 wk after the first
injection was administered.On d when injections were
administered, blood was drawn prior to any injection.
DCC Assay.Pituitary human growth hormone (hGH; NIDDK-hGH-
I-1, 2.2 IU/mg) was radiolabled with 131 (Amersham Corp.,
Arlington Heights, IL) using a modified chloramine-T method
(Hunter and Greenwood, 1962).Specific activity ranged from
90 to 120 ACi/Ag.Free iodine was separated from 125I-hGH by
anion exchange chromatography using a Biorad AG1-X8 resin
(50-100 mesh).The monomeric 125I-hGH was separated from
aggregated 125I-hGH by size exclusion chromatography using a
1 x 50 cm Biogel-P100 (Biorad, Hercules, CA) column eluted
at 4° C with PBS-0.5% BSA.The assay described by Davis et
al.(1992) was modified to measure 125I-hGH binding activity
in chicken serum as follows:Sample binding (SB) tubes were
prepared by adding 100 AL of approximately 20 K cpm [diluted
with PBS (pH 7.4)] to assay tubes (10 X 75 mm,
polypropylene) containing 350 gL assay buffer (PBS
containing 0.5% BSA and 75 mM MgC12) and 50 gL chicken
serum.Non-specific binding (NSB) tubes were identical to
SB tubes with the exception that 10 Al of 0.1 mg/AL36
unlabeled recombinant hGH4 (in expt. 1 and 2) or
pituitary hGH5 (in expt. 3 and 4) was substituted for 10 AL
of assay buffer.Total count (TC) tubes consisted of 400 gL
of assay buffer to which 100 gL of 125I-hGH was added.All
tubes were vortexed vigorously for 3 s and allowed to
incubate for 2 h at 23° C.Bound and unbound 1251-hGH were
separated by adding 500 gL of ice cold DCC (0.2% dextran,
Sigma; 2% activated charcoal, Sigma; in PBS) to each assay
tube.Tubes were vortexed vigorously for 3 s, and then
centrifuged at 2000 x g for 20 min at 4° C.Supernatants
were carefully removed from TC tubes and the remaining
pellet was counted.A 500 AL portion of the supernatant
from SB and NSB tubes was withdrawn from SB and NSB tubes
and counted.Radioactive emissions were counted for 2 min
per tube in a Beckman model 5500 Gamma Counter.
Specific binding was calculated as a % by subtracting
the respective NSB from the SB and dividing by the TC[
%SB =((SB- NSB) /TC) *100 ].All tubes were run in duplicate,
and averages were used for data analysis.The %SB is,
therefore, a measurement of relative cGHBP activity in these
studies.In order to prevent an assay effect from
confounding treatment effects, equal numbers of samples from
each group and sampling period were divided among the assays
necessary to complete all the samples in an experiment.
4Recombinant hGH (Novatropin ®) kindly provided by Genentech
5Pituitary purified hGH kindly provided by NIDDK.37
The last tubes in an assay may incubate for slightly longer
than the first tubes.To avoid an assay effect associated
with tube placement within an assay, all samples within each
assay were randomly assigned their placement by random
computer generated numbers.Intraassay variation was
measured by running 10 replicates of a pooled serum sample
(PSS; blood collected from 10 7-wk-old broilers at
slaughter) per assay.The PSS was used in duplicate to
measure the interassay variation and as an internal assay
control in all assays. Within any one assay, serum from
individual samples within the same treatment group were
pooled in order to obtain that groups' respective NSB value.
Although rare, occasionally very low to negative values were
obtained for samples.Most of these occurred in one
particular assay (the first assay we ran for experiment 1)
and so that entire assay was left out of the results.We
felt that any values < 1% SB should be discarded and not be
used for any calculations.Low %SB almost always occurred
along with very high NSB for the respective sample,
indicating that the problem was one inherent in the way in
which NSB's were obtained.
The inability of chicken prolactin6 (cPRL) to inhibit
6Chicken PRL kindly provided by Dr. A. F. Parlow, Harbor-UCLA
Medical Center, Torrance, CA.38
125I-hGH binding to cGHBP in concentrations up to 5 gg
cPRL/50 gL pooled chicken serum, confirms the specificity of
the assay.The intraassay and interassay coefficient of
variation was 5.9% (n=5) and 15.0% (n=6), respectively.
Statistical Analysis.Data were analyzed by single
classification ANOVA using the General Linear Models
procedure of the Statistical Analysis System (SAS Institute,
1982).39
Results and Discussion
Experiment 1.No significant difference (P>.05) in cGHBP
binding activity was detected between male and female birds
between hatch and 4 wk of age (Table 3).An interaction
between sex and age was evident in a comparison of body
weights at hatch (P>.05) and 4 wk of age (P<.0001).
Therefore, the difference in growth rate between sexes
appears to be independent of any action of biologically
active cGHBP in young broilers.The cGHBP activity in
chickens was highest (mean %SB= 14.6 ± 1.2) at hatch and
then decreased linearly (r= -.9516) to (mean %SB= 4.1 ± 0.6)
4 wk of age (Figure 1).Of the 107 samples assayed, 19 gave
%SB < 1% and thus were eliminated from this study.
Several reports have indicated that sex is not a factor
that influences GHBP activity (Silbergeld et al., 1989; Snow
et al., 1990; Baumann et al., 1989; Mullins and Davis,
1992).However, females have been reported with higher GHBP
activity than their male counterparts in rats (Mulumba et
al, 1991; Sadeghi et al., 1990) and humans (Barnard et al.,
1989; Massa et al., 1991).Where sexually dimorphic GHBP
activity has been observed, scatchard analysis has revealed
these differences to be a function of serum GHBP binding
capacity as opposed to GHBP affinity (Massa et al., 1990;
Amit et al., 1990).Massa et al.(1990) also showed that40
the high levels of GHBP found in females and the low levels
in males correlated positively with respective hepatic GHR
binding levels.
Secretion of GH is sexually dimorphic in the chicken
(Johnson, 1988; Harvey et al., 1979) and turkey (Bacon et
al., 1989; Harvey et al., 1977; Shaw et al., 1987) but GH
binding activity of hepatic tissue was not significantly
different between male and female turkeys until sexual
maturity had been reached (Vasilatos-Younken et al., 1990).
GH secretion in chickens increases from hatch until about 4
wk of age, at which point plasma GH levels decline
(Vasilatos-Younken and Zarkower, 1987; Harvey et al., 1979).
The same pattern has been shown in turkeys, with a GH peak
from 4 to 7 wk of age (Harvey et al., 1977).In the
chicken, hepatic GHR binding activity was low from hatch to
8 wk of age when compared to embryo and adult (2 yr old)
birds (Vanderpooten et al., 1991)Similar findings were
reported for the turkey (Vasilatos-Younken et al., 1990)
Vanderpooten et al.(1991) also found that differences
between dwarf and normal chicken hepatic GHR binding
activity were significant in embryo and adult birds, but
less so in young birds. In an initial study (E. Tobar-
Dupres, unpublished data), a line of dwarf leghorns had very
low to no detectable serum GHBP activity (n= 4, range= 0 to
2.5 %SB), while normal leghorns of the same age (2 yr old)
had an average %SB = 11.0 (n=4, range= 6.4 to 19.9).41
This apparent lack of serum GHBP in dwarf birds may be the
result of a deletion of the GHR gene (Burnside et al., 1991)
and may be comparable to the Laron Type Dwarfism in humans.
These data suggest that the lack of a sex effect on cGHBP
may be a factor of the age of the birds.Hepatic GHR
activity observed in chickens correlate with our findings as
well.
In addition, a qualitative study has described two
variants of cGHBP in an ontological study (Anderson et al.,
1992).Embryonic appearance of the 70 kD and 30 kD cGHBP
did not occur until d 12 and d 20 of incubation,
respectively.Each cGHBP increased progressively from the
age at which it was first observed to 1 d post-hatch.
Although prominent at hatching, the 70 kD cGHBP was greatly
diminished and the 30 kD cGHBP was not evident at 1 and 2 wk
post-hatch, but both reappeared at 4 wk post-hatch and
remained prominent at 6,8, 12, and 18 wk post-hatch.These
findings appear to correlate with our data.
Experiment 2 and 3.Neither fasting nor subsequent
refeeding caused a detectable difference (P>.05) in cGHBP
activity at any sampling point (Table 4). In addition, no
difference (P>.05) in cGHBP activity was observed in
response to feeding broiler chickens suboptimal diets (Table
5). However, ad libitum dietary treatments had a profound
effect on protein intake (51% of control CP consumption) and42
a moderate effect on energy consumption (81% of control ME
consumption) after 15 d of being fed nutrient poor diets.
Therefore, cGHBP activity appears to be independent of
nutritional status under the conditions of these studies.
Out of 114 samples assayed in experiment 2 and 233 samples
assayed in experiment 3, only 10 and 9 samples had %SB < 1%
in experiment 2 and 3, respectively.
Serum GHBP is low in humans under poor nutritional
conditions (Hizuka, 1991).Similarly, 50% reduction in
serum GHBP was seen in rats after a 3 d fast and normal
levels of GHBP were restored upon refeeding (Mulumba et al.,
1991).This reduction in GHBP was also shown to correlate
positively with hepatic GH receptor binding capacity.
Fasting in the rat has also been shown to diminish hepatic
GHR and GHBP mRNA levels (Straus and Takemoto, 1990).In
vitro glucose was shown to counteract the downregulation of
GH binding sites in primary cultured rat hepatocytes (Niimi
et al., 1991).Based on these studies, we had expected
fasting andprotein/energy deprivation to modulate cGHBP
activity.
Experiment 4. As shown in Table 6, CA administration had
no effect (P>.05) on cGHBP activity at any dose in samples
taken 24 h after the last CA injection.Blood serum drawn
at other periods, therefore, were not analyzed.43
In contrast, CA was very effective (P<.0001) at inhibiting
normal body weight gain in the group given 10 mg CA daily.
Controls gained 0.25 ± .01 kg over the 1 wk CA
administration interval, whereas birds given 10 mg CA daily
gained only 0.14 ± .01 kg.Thus the growth of the CA
treated birds was only 56% of the controls.
Based on data obtained from radioimmunoassays (Harvey
et al., 1986) basal peripheral corticosterone are
approximately 10 ng/mL of avian plasma.Assuming total
blood volume to be 7% of body weight, a 1.42 kg (mean weight
of all birds on d of first CA treatment)broiler chicken
would contain a total of 0.8 4g of circulating
corticosterone.Therefore, daily injection of 10 mg CA
provided 12,500 times the total amount of the broilers
principle glucocorticoid.Even so, such a dosage was
without effect (P>.05) on cGHBP (Table 6).No samples
assayed in this experiment had to be eliminated due to low
%SB.
Glucocorticoids have been shown to inhibit body weight
gain in chickens (Glick, 1960; Harvey and Scanes, 1979) and
rats (Silience and Etherton, 1991).Evidence suggests that
glucocorticoids induce GH transcription via binding to
glucocorticoid response elements on the GH gene (Rousseau et
al., 1987; Evans et al., 1982).Plasma GH levels rise in
chickens treated with glucocorticoids (Harvey and Scanes,
1979) .44
Thus, in addition to the factors of sex, age and diet, we
suspected that cGHBP activity would be modulated by
glucocorticoids.
In summary, of the factors evaluated, only age was
found to affect GHBP in broiler chickens (Table 3).
Paradoxically, cGHBP levels fell during a period of rapid
growth (Figure 1), were essentially inverse to reported
levels of circulating cGH, and were independent of factors
(sex, nutrient deprivation and CA administration) that had
profound effects on growth in young broiler chicks in these
studies.However, serum GHBP activity did appear to
correlate with reported GHR activity found in young birds.
The role of cGHBP in the growth process of the young broiler
is enigmatic.Due to the relatively high levels of cGHBP at
hatch and its subsequent decline, an argument could be
advanced that its primary role may be played during
embryonic development.It is also noteworthy that, in a
preliminary analysis, birds beginning 6 wk and up to 2 yr of
age had regained much of the cGHBP activity seen in birds a
hatch (Tobar-Dupres, unpublished data).Thus, a role for
GHBP could also be argued in older birds as well.45
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Table 1.Broiler starter/finisher feed rations.
Ingredients % in Starterl % in Finisher2
Corn 59.00 64.00
Animal Fat 2.00 2.00
Soybean Meal 32.50 27.75
Meat & Bone Meal 5.00 5.00
Monodical (16% Ca,21 %P) 0.35 0.25
Limestone 0.52 0.40
Salt 0.25 0.25
Trace Mineral Mix- 65 0.05 0.50
Vitamin Premix 0.20 0.20
DL-Methionine 0.13 0.10
Amproline 0.05 0.05
Baciform 0.05 0.05
Total 100.00 100.00
ICalculated:Crude Protein (CP)= 23%
Metabolizable Energy (ME)= 3151 Kcal/Kg
2Calculated:CP= 21%
ME= 3111 Kcal/Kg80
Table 2.Low Energy (LE), Low Protein (LP), and LE and LP
broiler feed rations.
Ingredients LE
1 LP
2
% in Feed
LELP3
Barley 30.00 0.00 50.00
Corn 28.00 85.50 30.00
Solka Floc 1.95 1.10 5.60
Soybean Meal 47.5% 27.75 8.00 9.00
Meat & Bone Meal 5.00 1.50 1.50
Monodical (16% Ca, 21 % P) 0.25 1.25 1.25
Limestone 0.40 1.25 1.25
Salt 0.25 0.25 0.25
Trace Mineral Mix - 65 0.05 0.05 0.05
Vitamin Premix 1-75 0.20 0.20 0.20
DL-Methionine 98% 0.10 0.25 0.25
Amproline 0.05 0.05 0.05
L-Lysine 86% 0.00 0.60 0.60
Total 100.00 100.00 100.00
ICalculated:Crude Protein (CP)= 21%
Metabolizable Energy (ME)= 2664 Kcal/Kg
2Calculated:CP= 12%
ME= 3154 Kcal/Kg
3Calculated:CP= 12%
ME= 2582 Kcal/Kg81
Table 3.Effect of sex on the level of chicken growth
hormone binding protein (cGHBP)in the serum of
broiler chickens.
Agee
(wk)
Sex Replicates
(n)
cGHBP3
(%SB)
0 M 10 16.1 ± 1.6
F 10 13.0 ± 1.7
1 M 14 9.8 ± 1.6
F 6 9.8 ± 2.1
2 M 11 6.8 ± 1.0
F 7 7.4 ± 1.1
3 M 7 7.6 ± 1.3
F 7 5.6 ± 1.2
4 M 8 4.0 ± 0.9
F 8 4.1 ± 0.8
lcGHBP level denotes a percentage of 13 1-hGH bound to
chicken serum protein following removal of unbound 1251-hGH
with dextran-coated charcoal.
2"0" wk denotes birds at hatch.
3Each value denotes a Mean ± SEM.82
Table 4.The effect of fasting and refeeding on the level
of chicken growth hormone binding protein (CGHBP)
in the serum of male broiler chickens2.
Sampling Period3
(h)
Group Replicates
(n)
GHBP4
(%SB)
0 Treatment 6 5.6 ± 1.8
Control 13 6.8 ± 0.7
12 Treatment 15 5.7 ± 0.6
Control 15 4.3 ± 0.5
24 Treatment 14 4.5 ± 0.4
Control 15 4.4 ± 0.5
48 Treatment 14 4.0 ± 0.4
Control 12 4.9 ± 0.7
1cGHBP level denotes a percentage of
1251-hGH bound to
chicken serum protein following removal of unbound 1251-hGH
with dextran-coated charcoal.
2All birds in this study were fasted at 4 wk of age.
3The "0" denotes a time point immediately after a 24 h
fast and just before refeeding.All other time points denote
h after refeeding.
4Each value denotes a Mean ± SEM.Table 5.The effect of a low proteinl(LP),
and low protein/low energy3(LELP)
a control4(CTRL) diet on the level'
hormone binding protein (cGHBP)
male broiler chickens.
83
low energy2(LE),
diet compared to
of chicken growth
in the serum of
Days on Treatment's Treatment Chickens
(d) (n)
cGHBP7
(%SB)
1 LE 9 4.03 ± 1.03
LP 10 6.03 ± 0.84
LELP 10 4.52 ± 0.78
CTRL 9 5.08 ± 0.78
7 LE 12 5.63 ± 0.36
LP 12 5.94 ± 0.47
LELP 10 5.60 ± 0.85
CTRL 12 5.99 ± 0.59
14 LE 12 5.66 ± 0.58
LP 11 5.12 ± 0.34
LELP 11 5.82 ± 0.87
CTRL 12 5.69 ± 0.55
21 LE 15 5.93 ± 0.79
LP 12 5.09 ± 0.59
LELP 11 6.26 ± 0.87
CTRL 12 6.75 ± 0.55
28 LE 11 5.34 ± 0.37
LP 12 6.30 ± 0.59
LELP 11 5.60 ± 0.64
CTRL 10 6.36 ± 0.62
112% crude protein.
22664 Kcal/Kg ME.
312% crude protein; 2582 Kcal/Kg ME.
421-23% crude protein; 3151-3111 Kcal/Kg ME.
5cGHBP level denotes a percentage of
125I-hGH bound to chicken
serum protein followed removal of unbound125I-hGH with dextran-
coated charcoal.
6Treatment diets began when birds reached 14 d of age
7Each value denotes a Mean ± SEM.84
Table 6.Effect of daily cortisone acetate (CA)
Administrationl on the level 2of chicken growth
hormone binding protein (cGHBP) in the serum of male
broiler chickens.
Treatment
(mg/d)
Replicates
(n)
cGHBP3
(%SB)
None 14 9.6 ± 0.7
1 mg 15 10.1 ± 1.0
5 mg 13 11.4 ± 1.1
10 mg 15 10.5 ± 0.6
1Each bird received 0.5 ml of corn oil, with or without CA,
per day.Injections were administered in the breast muscle at 24
h intervalsfor seven consecutive days. Blood samples were
collected 24 h after the last CA injection.
2cGHBP level denotes a percentage of
1251-hGH bound to chicken
serum protein following removal of unbound125I-hGH with dextran-
coated charcoal.
3Each value denotes a Mean ± SEM.85
Legend to Figure
Figure 1.The specific binding of 1251-hGH to chicken
serum growth hormone binding protein as a
function of time.Data points represent means.
The solid line represents the function:
y(x)= 13.3 - 2.46(x),
where 13.1 and -2.46 are estimates of the
parameters a and fl, respectively.The
correlation coefficient for the predicted line
was -.9516.16 -
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